Soluble receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation

Chun Hsiung Chen, Hung An Chen, Hsien Tzung Liao, Chin Hsiu Liu, Chang Youh Tsai, Chung Tei Chou

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The objective of the study was to investigate the role of receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) in ankylosing spondylitis (AS). Serum levels of soluble RANKL (sRANKL) and OPG were measured in 42 AS patients and 26 healthy controls. We evaluated the AS patient's disease activity, functional ability, global assessment, and physical mobility and tested markers of systemic inflammation, erythrocyte sedimentation rate (ESR), and Creactive protein (CRP) levels. Serum levels of sRANKL [mean (SD), 4.75 (1.88) vs. 3.70 (1.14) pmol/l, p=0.015] and OPG [mean (SD), 5.18 (1.19) vs. 4.52 (0.85) pmol/l, p=0.026] were significantly higher in the 42 AS patients than the 26 healthy controls. Interestingly, serum OPG levels correlated significantly with ESR (r=0.417, p= 0.007), CRP (r=0.524, p

Original languageEnglish
Pages (from-to)1155-1161
Number of pages7
JournalClinical Rheumatology
Volume29
Issue number10
DOIs
Publication statusPublished - 2010

Fingerprint

RANK Ligand
Osteoprotegerin
Ankylosing Spondylitis
Cytoplasmic and Nuclear Receptors
Inflammation
Blood Sedimentation
Serum
Proteins

Keywords

  • Ankylosing spondylitis
  • Inflammation
  • OPG
  • Physical mobility
  • RANKL

ASJC Scopus subject areas

  • Rheumatology

Cite this

Soluble receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis : OPG is associated with poor physical mobility and reflects systemic inflammation. / Chen, Chun Hsiung; Chen, Hung An; Liao, Hsien Tzung; Liu, Chin Hsiu; Tsai, Chang Youh; Chou, Chung Tei.

In: Clinical Rheumatology, Vol. 29, No. 10, 2010, p. 1155-1161.

Research output: Contribution to journalArticle

Chen, Chun Hsiung ; Chen, Hung An ; Liao, Hsien Tzung ; Liu, Chin Hsiu ; Tsai, Chang Youh ; Chou, Chung Tei. / Soluble receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis : OPG is associated with poor physical mobility and reflects systemic inflammation. In: Clinical Rheumatology. 2010 ; Vol. 29, No. 10. pp. 1155-1161.
@article{51b71cffbad74812b307911efe563d50,
title = "Soluble receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation",
abstract = "The objective of the study was to investigate the role of receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) in ankylosing spondylitis (AS). Serum levels of soluble RANKL (sRANKL) and OPG were measured in 42 AS patients and 26 healthy controls. We evaluated the AS patient's disease activity, functional ability, global assessment, and physical mobility and tested markers of systemic inflammation, erythrocyte sedimentation rate (ESR), and Creactive protein (CRP) levels. Serum levels of sRANKL [mean (SD), 4.75 (1.88) vs. 3.70 (1.14) pmol/l, p=0.015] and OPG [mean (SD), 5.18 (1.19) vs. 4.52 (0.85) pmol/l, p=0.026] were significantly higher in the 42 AS patients than the 26 healthy controls. Interestingly, serum OPG levels correlated significantly with ESR (r=0.417, p= 0.007), CRP (r=0.524, p",
keywords = "Ankylosing spondylitis, Inflammation, OPG, Physical mobility, RANKL",
author = "Chen, {Chun Hsiung} and Chen, {Hung An} and Liao, {Hsien Tzung} and Liu, {Chin Hsiu} and Tsai, {Chang Youh} and Chou, {Chung Tei}",
year = "2010",
doi = "10.1007/s10067-010-1543-y",
language = "English",
volume = "29",
pages = "1155--1161",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "10",

}

TY - JOUR

T1 - Soluble receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis

T2 - OPG is associated with poor physical mobility and reflects systemic inflammation

AU - Chen, Chun Hsiung

AU - Chen, Hung An

AU - Liao, Hsien Tzung

AU - Liu, Chin Hsiu

AU - Tsai, Chang Youh

AU - Chou, Chung Tei

PY - 2010

Y1 - 2010

N2 - The objective of the study was to investigate the role of receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) in ankylosing spondylitis (AS). Serum levels of soluble RANKL (sRANKL) and OPG were measured in 42 AS patients and 26 healthy controls. We evaluated the AS patient's disease activity, functional ability, global assessment, and physical mobility and tested markers of systemic inflammation, erythrocyte sedimentation rate (ESR), and Creactive protein (CRP) levels. Serum levels of sRANKL [mean (SD), 4.75 (1.88) vs. 3.70 (1.14) pmol/l, p=0.015] and OPG [mean (SD), 5.18 (1.19) vs. 4.52 (0.85) pmol/l, p=0.026] were significantly higher in the 42 AS patients than the 26 healthy controls. Interestingly, serum OPG levels correlated significantly with ESR (r=0.417, p= 0.007), CRP (r=0.524, p

AB - The objective of the study was to investigate the role of receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) in ankylosing spondylitis (AS). Serum levels of soluble RANKL (sRANKL) and OPG were measured in 42 AS patients and 26 healthy controls. We evaluated the AS patient's disease activity, functional ability, global assessment, and physical mobility and tested markers of systemic inflammation, erythrocyte sedimentation rate (ESR), and Creactive protein (CRP) levels. Serum levels of sRANKL [mean (SD), 4.75 (1.88) vs. 3.70 (1.14) pmol/l, p=0.015] and OPG [mean (SD), 5.18 (1.19) vs. 4.52 (0.85) pmol/l, p=0.026] were significantly higher in the 42 AS patients than the 26 healthy controls. Interestingly, serum OPG levels correlated significantly with ESR (r=0.417, p= 0.007), CRP (r=0.524, p

KW - Ankylosing spondylitis

KW - Inflammation

KW - OPG

KW - Physical mobility

KW - RANKL

UR - http://www.scopus.com/inward/record.url?scp=79952113849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952113849&partnerID=8YFLogxK

U2 - 10.1007/s10067-010-1543-y

DO - 10.1007/s10067-010-1543-y

M3 - Article

C2 - 20690034

AN - SCOPUS:79952113849

VL - 29

SP - 1155

EP - 1161

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 10

ER -